5 insights for improving pharmaceutical market access in Asia-Pacific

In this market access update, Jeff explains that while APAC markets may appear to be particularly complex, market access strategies will be improved by: First, let’s start with some basic definitions of what we mean by APAC for this discussion. Most companies would include China, Japan, Korea, Taiwan, Hong Kong, Southeast Asia (Singapore, Malaysia, Indonesia, Thailand, Vietnam, the Philippines), Australia, New Zealand, and India as markets of interest in the APAC region.

Read the source article at PRMA Consulting
2021-11-12 11:29:34